Cellular Origins

Cellular Origins

Private
MelbournHealthcare & Life Scienceshttps://cellularorigins.com

Last Round

Series A

Dec 9, 2025

Total Funding Raised

$40M

Momentum Score

100 /100

Company Overview

Cellular Origins is a biotechnology company that provides a robotic automation platform, Constellation, designed for the scalable, cost-effective, and efficient manufacture of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Industrial Robotics, Biotech Equipment, Workflow Automation, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

cell therapy automationCGT manufacturingmanufacturing scale-uprobotic automationbioprocessing automationautomation platformcell and gene therapiesCDMOcontract development and manufacturing organizationcell therapy factoryequipment integrationscale-out manufacturingautonomous mobile robotsGMP manufacturinglab automationsterile fluid transfer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellular Origins Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellular Origins Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ADec 9, 2025

Key People

Founding team and executive leadership

Dan Strange

Chief Technology Officer

Executive Team

Peter Crossley

Chief Operating Officer

Executive Team

Cellular Origins Investors

Notable investors and investment history

InvestorRounds
TTP GroupSeries A
BGFSeries A
Johnson & Johnson Innovation - JJDC, Inc.Series A
NYBC VenturesSeries A
Highland EuropeSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Grew 19% QoQ, from 80 to 95 employees.

  • Apr 15, 2026

    Monthly visitors increased 61% MoM, reaching 9.6K.

Cellular Origins Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellular Origins Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellular Origins's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourn
Employee Range95
Year Founded2022
Last FundingDec 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.